SEC Form 4 · accession 0001179110-17-014379
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J Blaser
Officer — Executive Vice President
Period of report
Nov 17, 2017
Accepted (ET)
Nov 20, 2017 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Nov 17, 2017 | M | 3,233 | $26.1879 | A | 146,387 | D | |
| Common shares without par value | Nov 17, 2017 | M | 6,333 | $23.228 | A | 152,720 | D | |
| Common shares without par value | Nov 17, 2017 | S | 2,700 | $55.575 | D | 150,020 | D | |
| Common shares without par value | Nov 17, 2017 | S | 1,000 | $55.571 | D | 149,020 | D | |
| Common shares without par value | Nov 17, 2017 | S | 3,944 | $55.57 | D | 145,076 | D | |
| Common shares without par value | Nov 17, 2017 | S | 1,922 | $55.565 | D | 143,154 | D | |
| Common shares without par value | Nov 17, 2017 | S | 2,000 | $55.53 | D | 141,154 | D | |
| Common shares without par value | Nov 17, 2017 | S | 900 | $55.5301 | D | 140,254 | D | |
| Common shares without par value | Nov 17, 2017 | S | 713 | $55.531 | D | 139,541 | D | |
| Common shares without par value | Nov 17, 2017 | S | 200 | $55.532 | D | 139,341 | D | |
| Common shares without par value | Nov 17, 2017 | S | 200 | $55.5321 | D | 139,141 | D | |
| Common shares without par value | Nov 17, 2017 | S | 10,287 | $55.535 | D | 128,854 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.1879 | Nov 17, 2017 | M | 3,233 | D | Feb 19, 2013 | Feb 18, 2020 | Common shares | 3,233 | 0 | D |
| Option (right to buy)F1 | $23.228 | Nov 17, 2017 | M | 6,333 | D | May 17, 2013 | May 16, 2020 | Common shares | 6,333 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.